Lotus Pharm vs BONRAYBIO: monthly revenue

Monthly revenue and year-on-year change for Lotus Pharm (1795) and BONRAYBIO (6955) over the past 13 months. The chart compares year-on-year growth rather than amounts, since the companies differ in size.

Year-on-year change

━ Lotus Pharm ━ BONRAYBIO

0%+226%-22%25/1026/0126/0426/0726/10

Monthly revenue history

MonthLotus PharmYoYBONRAYBIOYoY
Oct 2026NT$2.13 billion-22.5%NT$32.2 million+30.1%
Sep 2026NT$2.77 billion+128.0%NT$30 million+14.5%
Aug 2026NT$2.11 billion+81.7%NT$30.7 million+21.4%
Jul 2026NT$2.49 billion+3.9%NT$26.4 million+21.3%
Jun 2026NT$3.4 billion+225.5%NT$33.4 million+30.1%
May 2026NT$2.32 billion+105.8%NT$30 million+12.6%
Apr 2026NT$3.09 billion+19.9%NT$28.9 million+5.3%
Mar 2026NT$4.35 billion+173.6%NT$31.1 million+20.2%
Feb 2026NT$2.24 billion+131.5%NT$26.9 million+13.0%
Jan 2026NT$2.05 billion-5.5%NT$26.4 million+23.5%
Dec 2025NT$2.44 billion+66.9%NT$31.4 million+29.4%
Nov 2025NT$1.06 billion-0.2%NT$26.1 million+22.0%
Oct 2025NT$2.75 billion+46.0%NT$24.7 million+42.4%

← All Taiwan listed & OTC companies

Sources: Taiwan Stock Exchange, monthly revenue of listed companies (Government Open Data Platform); Taipei Exchange, monthly revenue of OTC companies (TPEx OpenAPI); historical months from MOPS. Amounts in New Taiwan dollars. Changes calculated by this site from the source figures. Not investment advice. Updated: 2026-11-16